Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association ConsortiumSharon E. Johnatty, Jolanta Kupryjańczyk, Jonathan P. Tyrer et al.|Clinical Cancer Research|2015Cited by 38
Plasma pre-treatment T790M relative allelic frequency in patients with advanced EGFR-mutated non-small cell lung cancer predicts treatment response to subsequent-line osimertinibPei N. Ding, Victoria Bray, Tara L. Roberts et al.|Translational Lung Cancer Research|2021Cited by 11
FURTHER: A global study to evaluate furmonertinib in patients with EGFR mutant NSCLC including uncommon EGFR mutations (FURMO-002).Xiuning Le, Jie Wang, Ying Cheng et al.|Journal of Clinical Oncology|2024Cited by 5